Press releases

A new target-seeking affibody molecule can be used to visualize cancer tumors and to treat them. This has been shown in a dissertation by Ann-Charlott Steffen to be publicly defended at Uppsala University on April 22.

The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death. A study led by Mia Wadelius at Uppsala University in Sweden indicates that two genes may be the explanation. The findings are being published in the latest issue of The Pharmacogenomics Journal.

Using only computers, a research team at Uppsala University in Sweden has managed to reveal both the structure and the function of a newly discovered enzyme from the most dangerous malaria parasite, Plasmodium falciparum. All that was needed was the amino acid sequence of the enzyme. The findings may represent a breakthrough for future pharmaceutical research.

A new model for the interaction among the nerve cells of the cerebral cortex may be a step on the way to improving treatment for schizophrenia and ADHD. The model, which describes the function of three types of inhibitory nerve cells in the frontal lobe, is being presented in the scientific journal PNAS by researchers from Linköping University and elsewhere.